| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 07/30/2009 | WO2009033813A3 Use of a peptide as a therapeutic agent |
| 07/30/2009 | WO2009033774A3 Use of a laminin nonapeptide as a therapeutic agent |
| 07/30/2009 | WO2009033769A3 Use of cortistatin 14 and others as a therapeutic agent |
| 07/30/2009 | WO2009033722A8 Use of a octreotide as a therapeutic agent |
| 07/30/2009 | WO2008127975A3 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 07/30/2009 | WO2008052044A3 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192227 N-Acetylcysteine Compositions and Methods for Treating Acute Exacerbations of Inflammatory Lung Disease |
| 07/30/2009 | US20090192187 Dry powder formulation comprising an anticholinergic drug |
| 07/30/2009 | US20090192185 Medical product |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192171 5-Lipoxygenase-Activating Protein (FLAP) Inhibitors |
| 07/30/2009 | US20090192163 Novel Compounds |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191134 Stable aerosol pharmaceutical formulations |
| 07/30/2009 | US20090191133 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | US20090188491 Medicaments |
| 07/29/2009 | EP2083007A1 Tiotropium salts, method for creating same and medicinal formulations containing same |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2082738A1 Use of beta-hydroxy-beta-methylbutyrate to treat asthma |
| 07/29/2009 | EP2081939A1 Benzimidazole derivatives as selective acid pump inhibitors |
| 07/29/2009 | EP2081573A2 Use of a pharmaceutical composition comprising an anticholinergic for killing microorganisms and for treating respiratory tract infections |
| 07/29/2009 | EP1989200B1 [4-(benzo[b]thiophen-2-yl)-pyrimidin-2-yl]-amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases |
| 07/29/2009 | EP1664057B1 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases |
| 07/29/2009 | EP1644074B1 Portable electrotherapy device for knee joint maladies |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1268844B1 Modulating production of pneumococcal capsular polysaccharide |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN101491565A Use of Ixeris Sonchifolia Hance injection in preparing medicine for treating viral pneumonia |
| 07/29/2009 | CN101491564A Use of Ixeris Sonchifolia Hance injection in preparing anti-herpes simplex virus medicine |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519558C Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and the use thereof in the production of a medicament |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/29/2009 | CN100518748C Emulsion containing plant extract, method for producing said emulsion and for obtaining plant extract |
| 07/28/2009 | US7566786 enzyme inhibitor 4-[(3-methylphenyl)amino]-6-(methylsulfonyl)-3-quinolinecarboxamide; antiinflammatory agents for treatment, prophylaxis of inflammatory or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis or allergic rhinitis |
| 07/28/2009 | US7566781 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide |
| 07/28/2009 | US7566721 Substituted thienol[2,3-d]pyrimidines as kinase inhibitors |
| 07/28/2009 | US7566705 Combination of formoterol and mometasone furoate for asthma |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/23/2009 | WO2009090976A1 Transmucosal therapeutic preparation for nasal obstruction |
| 07/23/2009 | WO2009090933A1 Virus growing in hypoxic cell or virus vector expressing gene therein |
| 07/23/2009 | WO2009090010A1 Compositions comprising an antimuscarinic and a long-acting beta-agonist |
| 07/23/2009 | WO2009052081A4 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/23/2009 | WO2009046845A3 Use of a lactoferrin partial peptide peptide as a therapeutic agent |
| 07/23/2009 | WO2009043523A3 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 07/23/2009 | WO2009040084A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009040034A3 Use of a peptide as a therapeutic agent |
| 07/23/2009 | WO2009039973A3 Use of peptide arg-asn-ile-ala-glu-ile-ile-lys-asp-ile-oh or its combination with the peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/23/2009 | WO2009033816A3 Use of the combination of thymosin beta 10 and thymosin alpha 1 peptides as a therapeutic agent |
| 07/23/2009 | WO2009033773A3 Use endothelin 2, alone or combined with a nonapeptide, a peptide as a therapeutic agent |
| 07/23/2009 | WO2009033761A3 Use of a fragment of hcv nucleo protein, alone or together with endothelin-3, as a therapeutic agent |
| 07/23/2009 | WO2009001085A3 An inhalable composition comprising nicotine |
| 07/23/2009 | WO2008156550A3 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine |
| 07/23/2009 | WO2007092939A8 Antigenic gm-csf peptides and antibodies to gm-csf |
| 07/23/2009 | US20090186949 Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds |
| 07/23/2009 | US20090186914 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 07/23/2009 | US20090186895 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186105 Device and Composition for the Delivery of a Preservative-Free Balsamic Cream |
| 07/23/2009 | US20090186036 Anti-Alpha V Beta 6 Antibodies |
| 07/23/2009 | US20090186030 Antibodies that bind both bcma and taci |
| 07/23/2009 | US20090186022 Organic Compounds |
| 07/23/2009 | US20090186010 Methods for the identification of ikkalfa function and other genes useful for treatment of inflammatory diseases |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080523A1 Compositions comprising an antimuscarinic and a long-acting beta-agonist |
| 07/22/2009 | EP2079740A2 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase |
| 07/22/2009 | EP2079725A1 Piperidyl-propane-thiol ccr3 modulators |
| 07/22/2009 | EP2079681A1 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use |
| 07/22/2009 | EP2079676A1 Salts of dihydroxyanthraquinone carboxylic acids and their therapeutic use |
| 07/22/2009 | EP2079459A2 Method of treating asthma, allergic rhinitis, and skin disorders |
| 07/22/2009 | EP1391456B1 2-iminoimidazole derivatives |
| 07/22/2009 | EP1379224B1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516037C Nitrooxyderivatives of cyclooxygenase-2 inhibitors |
| 07/22/2009 | CN100516024C Amino-propanol derivatives |
| 07/22/2009 | CN100515427C self emulsifying soft capsule of breviscapine and its preparation |
| 07/22/2009 | CN100515422C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 07/21/2009 | US7563800 Substituted pyrazolo[3,4-D]pyrimidines as p38 map kinase inhibitors |
| 07/21/2009 | US7563799 preferential enzyme inhibitors comprising fused pyrazolo derivatives, used for treating arthritis, Crohns disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease |
| 07/21/2009 | US7563790 Pyridazine derivatives |
| 07/21/2009 | US7563768 Administering hepatocyte growth factor to suppress inflammation |
| 07/21/2009 | US7563459 Administering a glycoconjugated asialoorosomucoid and the stem cell to the mammal for drug delivering to a target tissue; regenerating heart tissue; tissue-targeted therapy, gene therapy |
| 07/21/2009 | CA2470809C 6-amino-morphinan derivatives, method of manufacturing them and their application |
| 07/21/2009 | CA2382098C Sustained-release, oral pharmaceutical forms of administration |
| 07/21/2009 | CA2379972C Prodrug of an ice inhibitor |
| 07/21/2009 | CA2367921C Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
| 07/16/2009 | WO2009089422A2 Inhalation drug products, systems and uses |
| 07/16/2009 | WO2009089312A1 (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid |
| 07/16/2009 | WO2009089027A1 Phosphodiesterase inhibitors |